2 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 35508865 | PLK4 inhibitor plus bortezomib exhibits a synergistic effect on treating multiple myeloma via inactivating PI3K/AKT signaling. | 2022 May 4 | 2 |
| 2 | 32126150 | Inhibition of PLK4 might enhance the anti-tumour effect of bortezomib on glioblastoma via PTEN/PI3K/AKT/mTOR signalling pathway. | 2020 Apr | 2 |